First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
Clinical trial NCT04863287 · COMPLETED
Trial details
- NCT number
- NCT04863287
- Sponsor
- MassBiologics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-11
- Primary completion
- 2022-08-16
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.